PLIANT THERAPEUTICS, INC. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Cheung Lily | Chief Human Resource Officer | Award / Grant | 25,875 | — | — | 50,425 | Jan 23, 2025 |
| Ouimette Mike | General Counsel & Corp. Sec'y | Award / Grant | 35,000 | — | — | 105,544 | Jan 23, 2025 |
| Hull Hans | Chief Business Officer | Award / Grant | 40,150 | — | — | 251,708 | Jan 23, 2025 |
| Lefebvre Eric | Chief Medical Officer | Award / Grant | 45,650 | — | — | 240,224 | Jan 23, 2025 |
| Cummings Keith Lamont | Chief Financial Officer | Award / Grant | 56,650 | — | — | 319,258 | Jan 23, 2025 |
| Coulie Bernard | President and CEO | Award / Grant | 162,500 | — | — | 593,017 | Jan 23, 2025 |
| Coulie Bernard | President and CEO | Sale | 52,419 | $11.20 | $587,093 | 430,517 | Jan 17, 2025 |
| Cummings Keith Lamont | Chief Financial Officer | Sale | 20,148 | $11.20 | $225,658 | 262,608 | Jan 17, 2025 |
| Hull Hans | Chief Business Officer | Sale | 15,936 | $11.20 | $178,483 | 211,558 | Jan 17, 2025 |
| Lefebvre Eric | Chief Medical Officer | Sale | 18,478 | $11.20 | $206,954 | 194,574 | Jan 17, 2025 |
| Cheung Lily | Chief Human Resource Officer | Sale | 3,740 | $11.20 | $41,888 | 24,550 | Jan 17, 2025 |
| Ouimette Mike | General Counsel & Corp. Sec'y | Sale | 10,230 | $10.99 | $112,428 | 70,544 | Jan 17, 2025 |
| Lefebvre Eric | Chief Medical Officer | Sale | 12,319 | $11.56 | $142,408 | 213,052 | Jul 10, 2024 |
| Hull Hans | Chief Business Officer | Sale | 9,900 | $11.56 | $114,444 | 227,494 | Jul 10, 2024 |
| Cummings Keith Lamont | Chief Financial Officer | Sale | 10,911 | $11.56 | $126,131 | 282,115 | Jul 10, 2024 |
| Coulie Bernard | President and CEO | Sale | 38,710 | $11.56 | $447,488 | 482,936 | Jul 10, 2024 |
| Ouimette Mike | General Counsel & Corp. Sec'y | Sale | 7,656 | $11.56 | $88,503 | 94,044 | Jul 10, 2024 |
| Lefebvre Eric | Chief Medical Officer | Award / Grant | 24,063 | — | — | 225,371 | Jul 9, 2024 |
| Hull Hans | Chief Business Officer | Award / Grant | 19,337 | — | — | 237,394 | Jul 9, 2024 |
| Cummings Keith Lamont | Chief Financial Officer | Award / Grant | 21,313 | — | — | 293,026 | Jul 9, 2024 |
| Coulie Bernard | President and CEO | Award / Grant | 75,625 | — | — | 521,646 | Jul 9, 2024 |
| Ouimette Mike | General Counsel & Corp. Sec'y | Award / Grant | 14,954 | — | — | 101,700 | Jul 9, 2024 |
| Cummings Keith Lamont | Chief Financial Officer | Option Exercise | 21,000 | $2.08 | $43,680 | 271,713 | May 2, 2024 |
| Lefebvre Eric | Chief Medical Officer | Award / Grant | 42,900 | — | — | 199,820 | Jan 23, 2024 |
| Hull Hans | Chief Business Officer | Award / Grant | 31,500 | — | — | 216,569 | Jan 23, 2024 |
| Ouimette Mike | General Counsel & Corp. Sec'y | Award / Grant | 31,500 | — | — | 86,746 | Jan 23, 2024 |
| Cummings Keith Lamont | Chief Financial Officer | Award / Grant | 55,250 | — | — | 249,855 | Jan 23, 2024 |
| Cheung Lily | Chief Human Resource Officer | Award / Grant | 26,000 | — | — | 26,795 | Jan 23, 2024 |
| Coulie Bernard | President and CEO | Award / Grant | 128,150 | — | — | 444,532 | Jan 23, 2024 |
| Cummings Keith Lamont | Chief Financial Officer | Sale | 9,781 | $17.23 | $168,527 | 194,605 | Jan 17, 2024 |
| Hull Hans | Chief Business Officer | Sale | 9,786 | $17.23 | $168,613 | 185,069 | Jan 17, 2024 |
| Coulie Bernard | President and CEO | Sale | 25,721 | $17.23 | $443,173 | 316,382 | Jan 17, 2024 |
| Lefebvre Eric | Chief Medical Officer | Sale | 10,295 | $17.23 | $177,383 | 156,920 | Jan 17, 2024 |
| Ouimette Mike | General Counsel & Corp. Sec'y | Sale | 5,197 | $17.23 | $89,544 | 55,246 | Jan 17, 2024 |
| Hull Hans | Chief Business Officer | Sale | 1,800 | $20.00 | $36,000 | 206,114 | Aug 4, 2023 |
| Ouimette Mike | General Counsel & Corp. Sec'y | Sale | 4,755 | $17.55 | $83,450 | 60,443 | Jul 20, 2023 |
| Ouimette Mike | General Counsel & Corp. Sec'y | Sale | 12,778 | $18.01 | $230,132 | 65,198 | Jul 17, 2023 |
| Lefebvre Eric | Chief Medical Officer | Sale | 22,321 | $18.01 | $402,001 | 167,215 | Jul 17, 2023 |
| Hull Hans | Chief Business Officer | Sale | 17,937 | $18.01 | $323,045 | 219,183 | Jul 17, 2023 |
| Cummings Keith Lamont | Chief Financial Officer | Sale | 19,771 | $18.01 | $356,076 | 203,999 | Jul 17, 2023 |
| Coulie Bernard | President and CEO | Sale | 70,150 | $18.01 | $1,263,402 | 342,103 | Jul 17, 2023 |
| Ouimette Mike | General Counsel & Corp. Sec'y | Award / Grant | 27,187 | — | — | 77,976 | Jul 14, 2023 |
| Lefebvre Eric | Chief Medical Officer | Award / Grant | 43,750 | — | — | 189,536 | Jul 14, 2023 |
| Hull Hans | Chief Business Officer | Award / Grant | 35,156 | — | — | 237,120 | Jul 14, 2023 |
| Cummings Keith Lamont | Chief Financial Officer | Award / Grant | 38,750 | — | — | 223,770 | Jul 14, 2023 |
| Coulie Bernard | President and CEO | Award / Grant | 137,500 | — | — | 412,253 | Jul 14, 2023 |
| Cummings Keith Lamont | Chief Financial Officer | Option Exercise | 30,750 | $2.08 | $63,960 | 185,020 | Jun 13, 2023 |
| Cummings Keith Lamont | Chief Financial Officer | Option Exercise | 5,800 | $2.08 | $12,064 | 154,270 | Jun 9, 2023 |
| Ouimette Mike | General Counsel & Corp. Sec'y | Sale | 4,874 | $26.52 | $129,258 | 53,666 | Apr 3, 2023 |
| Lefebvre Eric | Chief Medical Officer | Sale | 11,245 | $26.52 | $298,217 | 145,786 | Mar 30, 2023 |